Oculis Announces Positive Topline Results of Phase 2b RELIEF Trial with Licaminlimab, Designed to Transform the Treatment Paradigm of Dry Eye Disease with a Precision Medicine Strategy
GlobeNewswire
ZUG, Switzerland, June 10, 2024 (GLOBE NEWSWIRE) --
· Improvements in multiple sign efficacy endpoints were observed in..